article thumbnail

Nektar lifted by Merck alliance for bempeg, new trial funding

Pharma Phorum

Merck will pair Keytruda (pembrolizumab) with bempegaldesleukin (NKTR-214) – known as bempeg for short – in a phase 2/3 trial involving patients with squamous cell carcinoma of the head and neck (SCCHN) that if positive could support regulatory filings.

article thumbnail

Reducing lung transplant rejection aim of clinical trial funded with $22 million grant

Scienmag

Medicine & Health aim clinical funded grant lung million Reducing rejection transplant trialPhysicians at Washington University School of Medicine in St.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Government of Canada invests in clinical trial development in Canada through the Clinical Trials Fund

Pharma in Brief

On June 22, 2022, the Canadian Institutes of Health Research ( CIHR ) announced the launch of the Clinical Trials Fund ( CTF ), which will inject funding into Canada’s clinical trials environment. The Clinical Trials Fund. Clinical Trials Projects.

article thumbnail

Boston University taps Shimmer wearables for brain studies

Outsourcing Pharma

The trials, funded by the American Heart Association, will harness the companyâs Verisense wearable sensor platform to examine brain-heart health links.

article thumbnail

Oral immunotherapy induces remission of peanut allergy in some young children

Scienmag

A clinical trial funded by the National Institutes of Health has found that giving peanut oral immunotherapy to highly peanut-allergic children ages 1 to 3 years safely desensitized most of them to peanut and induced remission of peanut allergy in one-fifth.

article thumbnail

Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn for the Treatment of Partial Thickness Burns

BioTech 365

Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn for the Treatment of Partial Thickness Burns Synedgen Initiates Clinical Trial Assessing Combination of SynePure and Catasyn for the Treatment of Partial Thickness Burns – Trial funded by Defense Health … Continue reading → Business Wire

article thumbnail

NIH expands clinical trials to test convalescent plasma against COVID-19

Scienmag

Rigorous studies to build on earlier efforts to test the experimental treatment Two randomized, placebo-controlled clinical trials funded by the National Institutes of Health (NIH) are expanding enrollment to further evaluate convalescent plasma as a treatment for patients hospitalized with COVID-19. Medicine & Health Biology Clinical Trials Infectious/Emerging Diseases Medicine/Health Public Health

article thumbnail

Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy

Pharma Phorum

Adding Eli Lilly’s rheumatoid arthritis drug Olumiant (baricitinib) and Gilead Sciences’ remdesivir reduces recovery time in COVID-19 patients compared to remdesivir alone, says a new trial. The post Trial backs Lilly’s Olumiant plus remdesivir as combo COVID-19 therapy appeared first on.

article thumbnail

Regeneron and Lilly post new data backing COVID antibody cocktails

Pharma Phorum

Regeneron is considering an emergency filing for its antibody cocktail REGEN-COV to protect people against COVID-19 after early trial results showed it conferred 100% protection against symptomatic infection.

article thumbnail

Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail

Pharma Phorum

The first patients have been dosed in a trial of two AstraZeneca antibodies, collectively known as AZD7442, that are being developed to both treat and prevent coronavirus infections. The post Chasing Regeneron, AZ starts trials of its COVID-19 antibody cocktail appeared first on.

article thumbnail

New Hope Against Diseases Marked by Progressive Scarring of Lung Tissue

The Pharma Data

15, 2021 — An inhaled medication might make every day physical activity a bit easier for patients with serious scarring of the lungs, a new clinical trial finds. In this trial, patients using Tyvaso did not rate their quality of life any higher than placebo patients did.

Doctors 52
article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

Pharma Phorum

Elliott informed those in attendance that for the next five years, with about £5 billion in funding for pipelines across a network of research and institute centres in clinical trials, that the aim is for everyone to live a life free of cancer.

Nurses 78